Use route-specific product documentation
A label for an approved injectable product does not describe an unspecified nasal or research preparation. The intended route and actual formulation belong in the initial specification.
Documentation to request
Request manufacturer, concentration, excipients and labeling for the exact product. Have the reviewer distinguish finished-medicine purchasing from a compounding proposal.
Regulatory context: FDA: compounding, approval and quality standards. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.
Related guidance: Product-by-product review for hormone clinics. These references support a review, not a treatment recommendation or supply authorization.